BioNTech SE Q1 2020 Earnings Call Transcript - Thomson StreetEvents

BioNTech SE Q1 2020 Earnings Call Transcript

BioNTech SE Q1 2020 Earnings Call Transcript - Thomson StreetEvents
BioNTech SE Q1 2020 Earnings Call Transcript
Published May 12, 2020
12 pages (7014 words) — Published May 12, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BNTX.OQ earnings conference call or presentation 12-May-20 12:00pm GMT

  
Brief Excerpt:

...Operator Thank you for standing by and welcome to the BioNTech First Quarter 2020 Operational Progress and Financial Results Conference Call. (Operator Instructions) I must advise you the conference is being recorded today, Tuesday, the 12th of May 2020. I would now like to hand the call over to the Vice President, Investor Relations and Business Strategy, Sylke Maas. Please go ahead. Sylke Maas ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
BioNTech SE
Ticker
BNTX.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Matthew Thomas Holt - JP Morgan Chase & Co, Research Division - Analyst : This is Matthew on for Cory. So my first question is on BNT126 -- or 162. For the initial Phase I data in June or July, how many patients should we expect to see? And should we be thinking about this as both a safety and immunogenicity update?

Question: Matthew Thomas Holt - JP Morgan Chase & Co, Research Division - Analyst : Great. That's super helpful. And then, I guess, in regard to the Phase II program, based on the comments in your prepared remarks, I'm curious if we should expect this Phase II trial can start sometime in 2020 and that the trial size will be north of 1,000 patients.

Question: Arlinda Anna Lee - Canaccord Genuity Corp., Research Division - Analyst : I had a few on 162. You talked about having, by the end of June, 50 to 70 subjects worth of data. I'm wondering how granular that data might be; and if you will have data from just the first candidate or some of the other candidates as well; and if there might be -- on the granularity side, whether you might have enough granularity on the volunteer background. And as well, what kind of things are you looking for in order to move forward with one formulation versus -- or one candidate versus another one?

Table Of Contents

BioNTech SE Q3 2020 Earnings Call Transcript – 2020-11-10 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 10-Nov-20 1:00pm GMT

BioNTech SE Q2 2020 Earnings Call Transcript – 2020-08-11 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 11-Aug-20 12:00pm GMT

BioNTech SE To Present Early Positive Data From Ongoing Phase 1/2 Study of mRNA-Based Vaccine Candidate Against SARS-CoV-2 Call Transcript – 2020-07-01 – US$ 54.00 – Edited Transcript of BNTX.OQ conference call or presentation 1-Jul-20 3:00pm GMT

BioNTech SE at UBS Global Healthcare Conference (Virtual) Transcript – 2020-05-19 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 19-May-20 4:30pm GMT

BioNTech SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript – 2020-05-14 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 14-May-20 3:40pm GMT

BioNTech SE - Special Call Transcript – 2020-04-23 – US$ 54.00 – Edited Transcript of BNTX.OQ conference call or presentation 23-Apr-20 12:00pm GMT

Full Year 2019 BioNTech SE Earnings Call Transcript – 2020-03-31 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 31-Mar-20 12:00pm GMT

BioNTech SE at JPMorgan Healthcare Conference Transcript – 2020-01-15 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 15-Jan-20 3:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "BioNTech SE Q1 2020 Earnings Call Transcript" May 12, 2020. Alacra Store. May 11, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2020-BioNTech-SE-Earnings-Call-T13169159>
  
APA:
Thomson StreetEvents. (2020). BioNTech SE Q1 2020 Earnings Call Transcript May 12, 2020. New York, NY: Alacra Store. Retrieved May 11, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2020-BioNTech-SE-Earnings-Call-T13169159>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.